Atara Biotherapeutics (ATRA) Non Operating Investment Income (2014)

Atara Biotherapeutics (ATRA) reported Non Operating Investment Income of -$11000.0 for Q3 2014.

Atara Biotherapeutics (ATRA) Non Operating Investment Income (2014) Analysis & Trends

Atara Biotherapeutics has reported Non Operating Investment Income for 1 years, with the latest figure at -$11000.0 in Q3 2014.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Op. Investment Inc. (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - 235,807.00
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - 230,000.00
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn -
9 Abivax 94.37 Bn 94.37 Bn - -
10 Atara Biotherapeutics 134.61 Mn 126.21 Mn 392,000.00 -

Historic Data

Download Data
DateValue
Sep 30, 2014 -11,000.00
Sep 30, 2014 -11,000.00